We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
Earlier this year we heard how Mater Hospital Brisbane Emergency Department had begun a six-month trial of having a dedicated physiotherapist in the department.
For pregnant women the birthing journey is an incredibly important and personal experience, each patient will have their own unique wishes and needs but for women who ...
The Mater Inflammatory Bowel Disease (IBD) Research Group recently held their inaugural symposium to share novel research findings, and discuss innovation and the ...
For people with chronic respiratory diseases, pulmonary rehabilitation is an important part of recovery especially for those who remain symptomatic or continue to ...
New research aims to shed light on reducing the loss of speech and language in epilepsy patients who require brain surgery to manage the condition.
Mater has a robust hepatology service which treats patients impacted by a range of different concerns including fatty liver disease, viral hepatitis, autoimmune liver ...
Mater Research is now taking applications for the Betty McGrath Seeding Grants in conjunction with Mater Health, Mater Education and supported by the Mater Foundation.
Did you know 1 in 12 children aged between 3-17 will experience a disorder related to voice, speech, language, communication or swallowing?* While these disorders are ...
On the 28 July each year, World Hepatitis Day is held to raise awareness of the global burden of viral hepatitis and to influence change in the community.
Mater Mothers’ Hospital is calling for pregnant women to participate in an Australian-first trial using Sildenafil - commonly known as Viagra® - to reduce the risk of ...
Congratulations to Associate Professor Jakob Begun who has been named the new Director of Mater’s Gastroenterology services.